Results 171 to 180 of about 38,738 (212)
Some of the next articles are maybe not open access.
Neoadjuvant GLP-1 Receptor Agonists in Sleep Surgery
JAMA Otolaryngology–Head & Neck SurgeryThis Viewpoint examines the potential role of neoadjuvant and adjuvant glucagon-like peptide–1 (GLP-1) receptor agonist therapy in improving surgical outcomes for patients with obstructive sleep apnea and obesity.
Ryan Chin Taw, Cheong, Kenny Peter, Pang
openaire +2 more sources
Oral GLP-1 Receptor Agonists for Weight Loss
Cardiology in ReviewWith the increasing prevalence of obesity and the advent of new and highly effective antiobesity medications, there is renewed interest in novel antiobesity pharmacotherapy. Currently, the most effective medications for obesity are injectable medicines. There is a need to develop equally efficacious oral drugs to increase availability to patients. Oral
Dana, Krinsky +3 more
openaire +2 more sources
Delivery Device Patents on GLP-1 Receptor Agonists
JAMAThis study analyzed the US Food and Drug Administration–listed patents on glucagon-like peptide 1 (GLP-1) receptor agonists to determine their claim characteristics and the potential barriers they pose to generic entry.
Rasha, Alhiary +4 more
openaire +2 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes
The Medical Letter on Drugs and TherapeuticsTable: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 ...
openaire +2 more sources
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer
Ca-A Cancer Journal for Clinicians, 2020Grace M Choong +2 more
exaly
GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
New England Journal of Medicine, 2023Sean, Wharton, Manige, Konig
openaire +4 more sources